Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

News

  • 1
    News

    Histologic analysis of vaping-associated lung injury suggests chemical pneumonitis

    October 4, 2019

    Foamy macrophages and pneumocyte vacuolization were seen in all cases.

  • 1
    News

    Vaping-associated lung injury cases exceed 1,000

    October 3, 2019

    As of Oct. 1, there have been 1,080 confirmed and probable cases of lung injury associated with the use of e-cigarettes, or vaping.

  • News

    Lefamulin found noninferior to moxifloxacin for bacterial pneumonia

    October 1, 2019

    Oral lefamulin, the first pleuromutilin antibiotic approved for intravenous and oral administration, was noninferior to oral moxifloxacin for inducing an early clinical response in patients with bacterial pneumonia, acording to data from a global multicenter study of 738 individuals.

  • 1
    News

    Vitamin C infusion falls short for sepsis and ARDS patients

    October 1, 2019

    Vitamin C failed to improve organ dysfunction, inflammation, or vascular injury in adults with sepsis and ARDS.

  • 1
    News

    CDC reports most vaping lung disease linked to THC-containing cartridges

    September 27, 2019

    Most vaping cartridges were obtained on the street, from dealers, online, or from friends or social contacts.

  • 1
    News

    FUO, pneumonia often distinguishes influenza from RSV in hospitalized young children

    August 22, 2019

    LJUBLJANA, SLOVENIA – “These findings open new possibilities for antimicrobial stewardship in these groups of virally infected children.” Dr. Cihan Papan.

  • 1
    News

    FDA approves Xenleta for community-acquired bacterial pneumonia treatment

    August 20, 2019

    The approval was based on results from two trials with a total of 1,289 patients.

  • 1
    News

    FDA approves drug combo to treat highly resistant TB

    August 14, 2019

    The combination of pretomanid tablets with bedaquiline and linezolid primarily was approved for a limited population infected with drug resistant TB.

  • 1
    News

    Study: Cardiac biomarkers predicted CV events in CAP

    August 13, 2019

    The results suggest a change in usual practice is needed to reduce cardiovascular community-acquired pneumonia complications, according to a study author.

  • 1
    News

    Procalcitonin advocated to help rule out bacterial infections

    August 13, 2019

    SEATTLE – Use of procalcitonin may help decrease lumbar punctures and antibiotic exposure.

Previous1 … 85 86 87 88 89 … 187Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences